ARUP Laboratories now offers a test for pTau 217 to aid in the detection of Alzheimer’s disease pathology. This test is minimally invasive and more accessible than other types of diagnostic testing.
Join ARUP at the 2025 AAN Annual Meeting to explore the latest in diagnostic laboratory testing for autoimmune neurology, including a presentation on a new biomarker test for Alzheimer's disease.
Pramana, Inc., and ARUP are collaborating to improve the assessment of bone marrow biopsies and address other key diagnostic challenges in hematopathology.
Because an estimated one in 10 Americans lives with a rare disease, ARUP is committed to investing in the diagnostic research and innovation that will help bring them answers.
The award recognizes the work ARUP does to educate, advocate, and innovate while continuously pushing to improve patient care.
The partnership combines Tasso’s clinical grade blood collection solutions and ARUP’s gold standard testing capabilities to streamline and accelerate decentralized clinical research.
ARUP Laboratories is partnering with Augurex Life Sciences Corp. to include the 14-3-3η test in the ARUP test menu to enhance the early detection of rheumatoid arthritis.
Benjamin T. Bradley, MD, PhD, was awarded a grant to study the use of a self-collection blood sample device to increase access to hepatitis C virus testing in rural Utah counties.
Utah Business magazine gave ARUP Laboratories an Honorable Mention Innovation Award for the newly created Innovation Business Unit, which aims to accelerate advancements in laboratory medicine.
The new Sherrie Perkins Research and Innovation Collaboration Grant, designed to foster collaboration in healthcare, will fund cutting-edge research in lab medicine that could impact patient care.
















